Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Predictive Oncology Inc (POAI)

Predictive Oncology Inc (POAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,069
  • Shares Outstanding, K 4,063
  • Annual Sales, $ 1,780 K
  • Annual Income, $ -13,980 K
  • 60-Month Beta 1.39
  • Price/Sales 3.72
  • Price/Cash Flow N/A
  • Price/Book 0.86
Trade POAI with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1200 +57.14%
on 04/22/24
1.9499 -9.74%
on 04/11/24
unch (unch)
since 04/09/24
3-Month
1.1200 +57.14%
on 04/22/24
3.7600 -53.19%
on 02/22/24
-1.1700 (-39.93%)
since 02/09/24
52-Week
1.1200 +57.14%
on 04/22/24
7.1200 -75.28%
on 07/18/23
-1.6300 (-48.08%)
since 05/09/23

Most Recent Stories

More News
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:POAI),(NASDAQ:AGLE),(NASDAQ:TALS),(NASDAQ:MRTX) EQNX::TICKER_END

ONCY : 1.2400 (+5.08%)
ONC.TO : 1.69 (+4.32%)
AGLE : 12.01 (+8.79%)
TALS : 27.20 (-0.73%)
POAI : 1.7600 (+1.15%)
MRTX : 58.70 (-0.17%)
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs

/PRNewswire/ -- Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other...

ONC.TO : 1.69 (+4.32%)
ONCY : 1.2400 (+5.08%)
AGLE : 12.01 (+8.79%)
TALS : 27.20 (-0.73%)
POAI : 1.7600 (+1.15%)
MRTX : 58.70 (-0.17%)
Predictive Oncology Strengthens Business with Appointment of a Chief Scientific Officer and Consolidation and Expansion of its Research and Development Arm

EAGAN, Minn., July 26, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) today announced a strategic move to further strengthen its business...

POAI : 1.7600 (+1.15%)
Predictive Oncology Announces Closing of $7.2 Million Registered Direct Offerings

EAGAN, Minn., May 18, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven...

POAI : 1.7600 (+1.15%)
Predictive Oncology Announces $7.2 Million Registered Direct Offerings

EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven...

POAI : 1.7600 (+1.15%)
Predictive Oncology Reports First Quarter Financial Results

EAGAN, Minn., May 12, 2022 (GLOBE NEWSWIRE) -- The financial results from the first quarter we believe depicts a solid potential for growth in the...

POAI : 1.7600 (+1.15%)
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of 0% and 16.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

SENS : 0.4812 (+1.01%)
POAI : 1.7600 (+1.15%)
American Well Corporation (AMWL) Reports Q1 Loss, Lags Revenue Estimates

American Well Corporation (AMWL) delivered earnings and revenue surprises of -18.18% and 0.67%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

AMWL : 0.5125 (-1.06%)
POAI : 1.7600 (+1.15%)
Predictive Oncology Reports Year End 2021 Financial Results and Provides Business Update

EAGAN, Minn., March 31, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial...

POAI : 1.7600 (+1.15%)
Predictive Oncology validates Discovery 21 proof-of-concept campaign

Predictive Oncology's Discovery 21 campaign evaluated the ability of its PeDAL® platform to make high-confidence predictions in ovarian tumor samples....

POAI : 1.7600 (+1.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.

See More

Key Turning Points

3rd Resistance Point 1.8600
2nd Resistance Point 1.8200
1st Resistance Point 1.7900
Last Price 1.7600
1st Support Level 1.7200
2nd Support Level 1.6800
3rd Support Level 1.6500

See More

52-Week High 7.1200
Fibonacci 61.8% 4.8280
Fibonacci 50% 4.1200
Fibonacci 38.2% 3.4120
Last Price 1.7600
52-Week Low 1.1200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar